 David Bain
Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Progesterone | 17 | 2014 | 337 | 3.030 |
Why?
| | Thermodynamics | 19 | 2023 | 424 | 2.820 |
Why?
| | Promoter Regions, Genetic | 14 | 2015 | 1243 | 2.290 |
Why?
| | Receptors, Glucocorticoid | 6 | 2018 | 137 | 1.950 |
Why?
| | DNA | 10 | 2015 | 1444 | 1.680 |
Why?
| | Receptors, Steroid | 5 | 2015 | 46 | 1.400 |
Why?
| | Response Elements | 9 | 2018 | 90 | 1.400 |
Why?
| | Antibodies, Monoclonal | 4 | 2025 | 1474 | 1.360 |
Why?
| | Ultracentrifugation | 8 | 2018 | 52 | 1.030 |
Why?
| | Drug Industry | 2 | 2017 | 110 | 0.940 |
Why?
| | Protein Binding | 13 | 2015 | 2242 | 0.800 |
Why?
| | Sodium Chloride | 5 | 2023 | 140 | 0.770 |
Why?
| | Protons | 1 | 2023 | 94 | 0.760 |
Why?
| | Education, Pharmacy | 1 | 2024 | 133 | 0.750 |
Why?
| | Binding Sites | 15 | 2018 | 1316 | 0.740 |
Why?
| | Gene Expression Regulation | 8 | 2015 | 2608 | 0.730 |
Why?
| | Estrogen Receptor alpha | 2 | 2014 | 144 | 0.720 |
Why?
| | Protein Multimerization | 6 | 2021 | 194 | 0.650 |
Why?
| | Transcription, Genetic | 7 | 2014 | 1487 | 0.630 |
Why?
| | Curriculum | 1 | 2024 | 1039 | 0.530 |
Why?
| | Dynamic Light Scattering | 3 | 2023 | 7 | 0.520 |
Why?
| | Fungi | 1 | 2017 | 152 | 0.480 |
Why?
| | Dimerization | 7 | 2012 | 196 | 0.460 |
Why?
| | Receptors, Estrogen | 4 | 2015 | 412 | 0.460 |
Why?
| | Research Personnel | 1 | 2016 | 184 | 0.440 |
Why?
| | Teaching | 1 | 2016 | 237 | 0.420 |
Why?
| | Biological Products | 1 | 2017 | 239 | 0.420 |
Why?
| | Immunoglobulin G | 1 | 2018 | 900 | 0.410 |
Why?
| | Mammary Tumor Virus, Mouse | 2 | 2015 | 45 | 0.400 |
Why?
| | Proteins | 2 | 2012 | 1015 | 0.370 |
Why?
| | Protein Isoforms | 7 | 2012 | 398 | 0.370 |
Why?
| | Receptors, Androgen | 1 | 2013 | 153 | 0.370 |
Why?
| | Protein Structure, Tertiary | 5 | 2016 | 859 | 0.340 |
Why?
| | Biomedical Research | 1 | 2016 | 708 | 0.320 |
Why?
| | DNA-Binding Proteins | 7 | 2014 | 1485 | 0.310 |
Why?
| | Potassium | 1 | 2010 | 148 | 0.300 |
Why?
| | Kinetics | 5 | 2015 | 1655 | 0.300 |
Why?
| | Sodium | 1 | 2010 | 196 | 0.290 |
Why?
| | Models, Molecular | 4 | 2018 | 1604 | 0.280 |
Why?
| | Protein Footprinting | 1 | 2008 | 11 | 0.280 |
Why?
| | DNA Footprinting | 3 | 2015 | 33 | 0.280 |
Why?
| | Deoxyribonucleases | 1 | 2008 | 24 | 0.280 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2007 | 209 | 0.250 |
Why?
| | Recombinant Proteins | 4 | 2016 | 1363 | 0.240 |
Why?
| | Models, Biological | 3 | 2008 | 1828 | 0.240 |
Why?
| | Transcription Factors | 3 | 2012 | 1712 | 0.230 |
Why?
| | Silicone Oils | 1 | 2025 | 32 | 0.230 |
Why?
| | Humans | 33 | 2024 | 141754 | 0.230 |
Why?
| | Drug Compounding | 1 | 2025 | 104 | 0.230 |
Why?
| | Chemistry, Pharmaceutical | 2 | 2025 | 107 | 0.230 |
Why?
| | Trans-Activators | 1 | 2007 | 394 | 0.220 |
Why?
| | Molecular Sequence Data | 6 | 2012 | 2929 | 0.220 |
Why?
| | Transcriptional Activation | 3 | 2012 | 378 | 0.220 |
Why?
| | Faculty, Pharmacy | 1 | 2024 | 21 | 0.220 |
Why?
| | Schools, Pharmacy | 1 | 2024 | 49 | 0.210 |
Why?
| | Protein Conformation | 5 | 2009 | 941 | 0.210 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2003 | 32 | 0.200 |
Why?
| | Antibodies | 1 | 2025 | 411 | 0.200 |
Why?
| | Students, Pharmacy | 1 | 2024 | 105 | 0.200 |
Why?
| | Proteaceae | 1 | 2022 | 1 | 0.200 |
Why?
| | Cytokines | 1 | 2011 | 2100 | 0.200 |
Why?
| | Base Sequence | 4 | 2012 | 2180 | 0.200 |
Why?
| | Xanthine Dehydrogenase | 1 | 2002 | 25 | 0.190 |
Why?
| | Xanthine Oxidase | 1 | 2002 | 81 | 0.180 |
Why?
| | Protein Aggregates | 2 | 2025 | 78 | 0.180 |
Why?
| | Oxidoreductases | 1 | 2002 | 96 | 0.180 |
Why?
| | Allosteric Regulation | 3 | 2010 | 89 | 0.170 |
Why?
| | Skin Physiological Phenomena | 1 | 2000 | 25 | 0.170 |
Why?
| | Static Electricity | 1 | 2021 | 113 | 0.170 |
Why?
| | Viral Proteins | 2 | 2001 | 369 | 0.160 |
Why?
| | Biophysical Phenomena | 2 | 2015 | 68 | 0.160 |
Why?
| | Pressure | 1 | 2000 | 230 | 0.160 |
Why?
| | Repressor Proteins | 5 | 2000 | 430 | 0.150 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1094 | 0.150 |
Why?
| | Chromatography, Gel | 2 | 2017 | 131 | 0.140 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 336 | 0.140 |
Why?
| | Manufacturing and Industrial Facilities | 1 | 2017 | 2 | 0.140 |
Why?
| | Hoarding Disorder | 1 | 2016 | 2 | 0.130 |
Why?
| | Self-Help Groups | 1 | 2016 | 37 | 0.120 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2017 | 129 | 0.120 |
Why?
| | Public-Private Sector Partnerships | 1 | 2016 | 45 | 0.120 |
Why?
| | Animals | 13 | 2018 | 37749 | 0.120 |
Why?
| | Luciferases | 2 | 2012 | 150 | 0.120 |
Why?
| | Structure-Activity Relationship | 2 | 2007 | 579 | 0.110 |
Why?
| | Transfection | 3 | 2012 | 943 | 0.110 |
Why?
| | NF-kappa B | 1 | 2018 | 692 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 2 | 2015 | 674 | 0.100 |
Why?
| | Mutation, Missense | 1 | 2015 | 340 | 0.100 |
Why?
| | Hydrolysis | 2 | 2005 | 196 | 0.100 |
Why?
| | Molecular Weight | 2 | 2005 | 329 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2012 | 4212 | 0.090 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 55 | 0.090 |
Why?
| | Progestins | 1 | 2012 | 81 | 0.090 |
Why?
| | Evolution, Molecular | 1 | 2015 | 510 | 0.090 |
Why?
| | Hydrodynamics | 1 | 2011 | 47 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2007 | 557 | 0.090 |
Why?
| | Algorithms | 1 | 2018 | 1768 | 0.080 |
Why?
| | Tamoxifen | 2 | 2000 | 203 | 0.080 |
Why?
| | Research Design | 1 | 2016 | 1146 | 0.080 |
Why?
| | Binding, Competitive | 2 | 2008 | 196 | 0.080 |
Why?
| | Biological Phenomena | 1 | 2009 | 4 | 0.080 |
Why?
| | Breast Neoplasms | 3 | 2012 | 2257 | 0.070 |
Why?
| | Tandem Repeat Sequences | 1 | 2008 | 20 | 0.070 |
Why?
| | Spodoptera | 1 | 2008 | 40 | 0.070 |
Why?
| | DNA Fingerprinting | 1 | 2007 | 29 | 0.070 |
Why?
| | Substrate Specificity | 1 | 2008 | 385 | 0.070 |
Why?
| | Allosteric Site | 1 | 2006 | 17 | 0.060 |
Why?
| | Silicon | 1 | 2025 | 21 | 0.060 |
Why?
| | Energy Metabolism | 1 | 2012 | 932 | 0.060 |
Why?
| | Salts | 1 | 2005 | 37 | 0.060 |
Why?
| | Syringes | 1 | 2025 | 46 | 0.060 |
Why?
| | MicroRNAs | 1 | 2012 | 692 | 0.060 |
Why?
| | Solutions | 1 | 2005 | 168 | 0.060 |
Why?
| | Spectrometry, Fluorescence | 1 | 2005 | 167 | 0.060 |
Why?
| | Peptide Hydrolases | 1 | 2005 | 113 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 404 | 0.050 |
Why?
| | Protein Structure, Quaternary | 1 | 2003 | 120 | 0.050 |
Why?
| | Ligands | 1 | 2005 | 667 | 0.050 |
Why?
| | Models, Genetic | 1 | 2006 | 592 | 0.050 |
Why?
| | Microscopy, Atomic Force | 1 | 2003 | 128 | 0.050 |
Why?
| | HeLa Cells | 3 | 2018 | 640 | 0.050 |
Why?
| | Models, Statistical | 1 | 2007 | 671 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2005 | 464 | 0.050 |
Why?
| | Chromatography | 1 | 2002 | 24 | 0.050 |
Why?
| | Chymotrypsin | 1 | 2002 | 23 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2002 | 112 | 0.050 |
Why?
| | Trypsin | 1 | 2002 | 76 | 0.050 |
Why?
| | Phenylalanine | 1 | 2002 | 67 | 0.050 |
Why?
| | Molecular Chaperones | 1 | 2003 | 198 | 0.050 |
Why?
| | Disulfides | 1 | 2002 | 99 | 0.050 |
Why?
| | Australia | 1 | 2022 | 311 | 0.040 |
Why?
| | Mifepristone | 2 | 2000 | 63 | 0.040 |
Why?
| | Methionine | 1 | 2002 | 159 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2002 | 208 | 0.040 |
Why?
| | Protein Denaturation | 1 | 2001 | 73 | 0.040 |
Why?
| | Estrogen Receptor Modulators | 1 | 2000 | 17 | 0.040 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2001 | 85 | 0.040 |
Why?
| | Circular Dichroism | 1 | 2001 | 148 | 0.040 |
Why?
| | Clothing | 1 | 2000 | 22 | 0.040 |
Why?
| | Cysteine | 1 | 2002 | 208 | 0.040 |
Why?
| | Biophysics | 1 | 2001 | 74 | 0.040 |
Why?
| | Bandages | 1 | 2000 | 42 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2002 | 418 | 0.040 |
Why?
| | Virus Assembly | 1 | 2001 | 79 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3356 | 0.040 |
Why?
| | Sulfhydryl Compounds | 1 | 2002 | 188 | 0.040 |
Why?
| | Endopeptidases | 1 | 2000 | 86 | 0.040 |
Why?
| | DNA Primers | 1 | 2001 | 510 | 0.040 |
Why?
| | Edema | 1 | 2000 | 131 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2002 | 595 | 0.040 |
Why?
| | Lysine | 1 | 2002 | 292 | 0.040 |
Why?
| | Cattle | 1 | 2002 | 998 | 0.040 |
Why?
| | Biodiversity | 1 | 2022 | 425 | 0.040 |
Why?
| | Protein Folding | 1 | 2000 | 278 | 0.040 |
Why?
| | Biological Evolution | 1 | 2022 | 493 | 0.040 |
Why?
| | Peptide Fragments | 2 | 2003 | 701 | 0.040 |
Why?
| | Phylogeny | 1 | 2022 | 1019 | 0.030 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 1998 | 28 | 0.030 |
Why?
| | Hot Temperature | 1 | 2001 | 406 | 0.030 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 1998 | 75 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2018 | 377 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2018 | 310 | 0.030 |
Why?
| | Ribosomal Proteins | 1 | 1997 | 92 | 0.030 |
Why?
| | Oxygen | 1 | 2002 | 992 | 0.030 |
Why?
| | Cold Temperature | 1 | 1998 | 196 | 0.030 |
Why?
| | Protein Stability | 1 | 2017 | 175 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2018 | 485 | 0.030 |
Why?
| | Nuclear Proteins | 2 | 2000 | 719 | 0.030 |
Why?
| | Burns | 1 | 2000 | 349 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 344 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 737 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2000 | 833 | 0.030 |
Why?
| | Comparative Effectiveness Research | 1 | 2016 | 164 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 1 | 1994 | 40 | 0.030 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1994 | 28 | 0.030 |
Why?
| | Potassium Chloride | 1 | 1994 | 42 | 0.030 |
Why?
| | Calibration | 1 | 2015 | 152 | 0.030 |
Why?
| | Bacteriophage lambda | 1 | 1994 | 89 | 0.030 |
Why?
| | Models, Chemical | 1 | 1994 | 272 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 1250 | 0.020 |
Why?
| | Operator Regions, Genetic | 1 | 1992 | 8 | 0.020 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 1992 | 14 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2012 | 116 | 0.020 |
Why?
| | Comorbidity | 1 | 2016 | 1664 | 0.020 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 149 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 274 | 0.020 |
Why?
| | Time Factors | 1 | 2002 | 6966 | 0.020 |
Why?
| | COS Cells | 2 | 2003 | 183 | 0.020 |
Why?
| | Male | 2 | 2016 | 70179 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 1992 | 377 | 0.020 |
Why?
| | Nuclear Receptor Co-Repressor 2 | 2 | 2000 | 14 | 0.020 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 2 | 2000 | 15 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 444 | 0.020 |
Why?
| | Mice | 2 | 2003 | 18109 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2903 | 0.020 |
Why?
| | Cell Movement | 1 | 2012 | 990 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 3495 | 0.010 |
Why?
| | Signal Transduction | 1 | 1996 | 5169 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2003 | 363 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 391 | 0.010 |
Why?
| | Mutagenesis | 1 | 2003 | 182 | 0.010 |
Why?
| | Nuclear Receptor Coactivator 1 | 1 | 2000 | 11 | 0.010 |
Why?
| | Female | 4 | 2016 | 75943 | 0.010 |
Why?
| | Histone Acetyltransferases | 1 | 2000 | 63 | 0.010 |
Why?
| | Drug Resistance | 1 | 2000 | 150 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2003 | 2158 | 0.010 |
Why?
| | Cell Division | 1 | 2000 | 798 | 0.010 |
Why?
| | Urocortins | 1 | 1998 | 23 | 0.010 |
Why?
| | Chimera | 1 | 1998 | 61 | 0.010 |
Why?
| | Leucine Zippers | 1 | 1997 | 16 | 0.010 |
Why?
| | Yeasts | 1 | 1997 | 52 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1997 | 274 | 0.010 |
Why?
| | DNA, Superhelical | 1 | 1992 | 11 | 0.010 |
Why?
| | Electrophoresis | 1 | 1992 | 32 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 1992 | 78 | 0.010 |
Why?
| | Plasmids | 1 | 1992 | 365 | 0.010 |
Why?
| | Rats | 1 | 1998 | 5637 | 0.000 |
Why?
|
|
Bain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|